Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Yokohama
Clinical trial register · Japan

Clinical Trials in Yokohama, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Sapporo 33 Nagoya 30 Yokohama 27 Fukuoka 19 Suita 19
Narrow the registerReset
Recruitment status
Phase
Site location
Sapporo33 Nagoya30 Yokohama27 Fukuoka19 Suita19
All 135 locations
Target enrolment
to

Trials with a site in Yokohama

27 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Novartis Pharmaceuticals
Phase 2
120
Yokohama, Suita, Hachiōji, Fukushima
2026-10-30
Recruiting
Novartis Pharmaceuticals
Phase 3
180
Yokohama, Sakai, Tachikawa
2026-08-24
Recruiting
Novartis Pharmaceuticals
Observational
10
Kobe, Ushiku, Kanoya, Yokohama, Osaka
2026-05-13
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
NCT07354074Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
Novartis Pharmaceuticals
Phase 2
50
Yokohama, Fukuoka, Saitama
2026-04-28
Recruiting
Novartis Pharmaceuticals
Phase 3
940
Nagoya, Sapporo, Kobe, Kamakura, Yokohama, Kumamoto, Chuo Ku, Chiba
2025-07-01
Recruiting
Novartis Pharmaceuticals
Phase 2
224
Nagoya, Matsudo, Kawasaki, Yokohama, Habikino, Shinagawa Ku, Fukuoka, Kyoto
2025-05-16
Recruiting
Novartis Pharmaceuticals
Phase 2/3
443
Kashiwa, Sapporo, Kobe, Yokohama, Chiba, Fukuoka, Fukushima, Ishikawa
2025-02-27
Recruiting
Novartis Pharmaceuticals
Observational
30
Ōbu, Toyoake, Kurume, Sapporo, Tsukuba, Kawasaki, Yokohama, Tsu
2024-12-19
Active, closed
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256Idiopathic Inflammatory Myopathies
Novartis Pharmaceuticals
Phase 2
21
Sapporo, Yokohama, Sendai, Suita, Izumo, Bunkyo-ku, Shinjuku-ku, Fukuoka
2024-12-17
Active, closed
Novartis Pharmaceuticals
Phase 2
201
Nagoya, Toyoake, Yokohama, Iruma-gun, Bunkyo-ku, Shinjuku Ku, Toyama, Hiroshima
2024-10-09
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Chiba, Sapporo, Kobe, Yokohama, Sendai, Suita, Izumo, Bunkyo Ku
2024-09-04
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Fukuoka, Asahikawa, Kita-gun, Sagamihara, Yokohama, Nagano, Kawachi-Nagano, Osaka
2024-06-28
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Nagoya, Sapporo, Yokohama, Sendai, Bunkyo-ku, Chuo Ku, Fuchū, Itabashi-ku
2024-05-21
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Kashiwa, Sapporo, Kobe, Yokohama, Chuo Ku, Fukuoka, Fukushima, Ishikawa
2024-03-12
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Nagoya, Kitakyushu, Sapporo, Yokohama, Kuwana, Sasebo, Kurashiki, Bunkyo Ku
2023-10-27
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
383
Kasugai-Shi, Toyoake-shi, Urayasu-Shi, Sapporo, Kitakyushu, Yokohama, Kashihara, Nara
2023-07-06
Active, closed
Novartis Pharmaceuticals
Phase 3
436
Nagoya, Sapporo, Yokohama, Sendai, Bunkyo Ku, Bunkyo-ku, Chuo Ku, Fuchū
2023-03-02
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Nagoya, Urayasu, Obihiro, Yokohama, Kamimashi-gun, Izumiōtsu, Neyagawa, Sakai
2022-12-09
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Nagoya, Kitakyushu, Sapporo, Yokohama, Kuwana, Sasebo, Kurashiki, Bunkyo Ku
2022-08-04
Recruiting
Novartis Pharmaceuticals
Phase 1/2
34
Yokohama, Shinjuku-ku, Osaka
2021-12-27
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Toyota, Chikushino-shi, Kanazawa, Komatsu, Fujisawa, Odawara, Yokohama, Nagaoka
2021-11-23
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Kasugai, Toyoake, Toyota, Sapporo, Kawasaki, Yokohama, Kyoto, Sendai
2021-09-20
Active, closed
Novartis Pharmaceuticals
Phase 3
1,140
Nagoya, Sapporo, Kobe, Yokohama, Kumamoto, Suita, Kitaadachi-gun, Bunkyo Ku
2021-06-09
Active, closed
Novartis Pharmaceuticals
Phase 2
36
Narita, Kurume, Ohtake, Nishinomiya, Kanazawa, Isehara, Yokohama, Sendai
2021-05-25
Active, closed
Novartis Pharmaceuticals
Phase 2
24
Nagoya, Kashiwa, Isehara, Yokohama, Kumamoto, Sendai, Osaka, Suita
2021-01-08
Recruiting
Novartis Pharmaceuticals
Observational
700
Nagakute-shi, Toyoake-shi, Chiba, Kurume-shi, Gifu, Sapporo, Kita-gun, Yokohama
2018-09-25
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/yokohama

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies with a site in Yokohama that also match the filters currently applied.

How many clinical trials are recruiting in Yokohama?

14 of the 27 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Yokohama), 27 studies
PhaseStudiesRecruitingShare
Phase 314651.9%
Phase 28329.6%
Observational3311.1%
Phase 1/2113.7%
Phase 2/3113.7%

Most active sponsors

Lead sponsors with the most studies (Yokohama)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals2714
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.